Literature DB >> 24106135

Biopsychosocial typologies of pain in a cohort of patients with systemic sclerosis.

Erin L Merz1, Vanessa L Malcarne, Shervin Assassi, Deepthi K Nair, Tiffany A Graham, Brayden P Yellman, Rosa M Estrada-Y-Martin, Maureen D Mayes.   

Abstract

OBJECTIVE: Despite being a common problem in systemic sclerosis (SSc; scleroderma), the extant literature on pain has primarily focused on biomedical correlates, or bivariate relationships with a few psychological characteristics. There is a need to investigate the more heuristic biopsychosocial model, which incorporates the simultaneous contributions of medical, psychological, and social variables in understanding pain.
METHODS: Patients with SSc (n = 333) received clinical examinations and completed self-report surveys at enrollment in the Genetics versus Environment in Scleroderma Outcome Study. Latent profile analysis was used to derive biopsychosocial profiles of patients using skin thickening, percent predicted forced vital lung capacity, perceived physical health, health worry, mental health, and social support. The profiles were examined in relation to pain and pain medication usage.
RESULTS: A 3-profile solution provided the best fit to the data. Based on the biopsychosocial indicators, the profiles were characterized as managing (n = 217), resilient (n = 86), and distressed (n = 30). Between-group differences for pain emerged, with the distressed group, whose disease was less severe than the resilient group, reporting the highest pain and the greatest utilization of pain medication.
CONCLUSION: Clinicians should consider biopsychosocial characteristics as contributing factors to the experience of pain in patients with SSc. Patients who are similar to those in the distressed profile may be at an increased risk for pain and would likely benefit from a referral to a behavioral health or other ancillary service provider for pain management, rather than relying solely on pharmacologic therapies.
Copyright © 2014 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24106135      PMCID: PMC3960366          DOI: 10.1002/acr.22171

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  36 in total

1.  Impact of pain in health related quality of life of patients with systemic sclerosis.

Authors:  C Georges; O Chassany; C Toledano; L Mouthon; K Tiev; O Meyer; D Ilie; J Rambeloarisoa; Z Marjanovic; J Cabane; D Sereni; J Pouchot; D Farge
Journal:  Rheumatology (Oxford)       Date:  2006-06-04       Impact factor: 7.580

2.  'Quality of pain' in systemic sclerosis.

Authors:  P E Carreira
Journal:  Rheumatology (Oxford)       Date:  2006-08-09       Impact factor: 7.580

Review 3.  Systemic sclerosis - continuing progress in developing clinical measures of response.

Authors:  Daniel Furst; Dinesh Khanna; Marco Matucci-Cerinic; Philip Clements; Virginia Steen; Janet Pope; Peter Merkel; Ivan Foeldvari; James Seibold; David Pittrow; Richard Polisson; Vibeke Strand
Journal:  J Rheumatol       Date:  2007-05       Impact factor: 4.666

4.  Clinical features and personality traits associated with psychological distress in systemic sclerosis patients.

Authors:  Thomas N Hyphantis; Niki Tsifetaki; Christina Pappa; Paraskevi V Voulgari; Vasiliki Siafaka; Marina Bai; Yannis Alamanos; Alexandros A Drosos; Venetsanos Mavreas
Journal:  J Psychosom Res       Date:  2007-01       Impact factor: 3.006

5.  Social support, coping and subjective well-being in patients with rheumatic diseases.

Authors:  M Savelkoul; M W Post; L P de Witte; H B van den Borne
Journal:  Patient Educ Couns       Date:  2000-02

6.  Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis.

Authors:  Vanessa L Malcarne; Ingunn Hansdottir; Ann McKinney; Renn Upchurch; Helen L Greenbergs; Gretchen H Henstorf; Daniel E Furst; Philip J Clements; Michael H Weisman
Journal:  J Rheumatol       Date:  2007-02       Impact factor: 4.666

7.  The impact of pain and symptoms of depression in scleroderma.

Authors:  Lisa M Benrud-Larson; Jennifer A Haythornthwaite; Leslie J Heinberg; Christy Boling; Jeffrey Reed; Barbara White; Fredrick M Wigley
Journal:  Pain       Date:  2002-02       Impact factor: 6.961

Review 8.  Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being.

Authors:  Thomas A Medsger
Journal:  Rheum Dis Clin North Am       Date:  2003-05       Impact factor: 2.670

Review 9.  Psychologic factors in scleroderma.

Authors:  Jennifer A Haythornthwaite; Leslie J Heinberg; Lynanne McGuire
Journal:  Rheum Dis Clin North Am       Date:  2003-05       Impact factor: 2.670

Review 10.  The biopsychosocial approach to chronic pain: scientific advances and future directions.

Authors:  Robert J Gatchel; Yuan Bo Peng; Madelon L Peters; Perry N Fuchs; Dennis C Turk
Journal:  Psychol Bull       Date:  2007-07       Impact factor: 17.737

View more
  3 in total

1.  Olfactory impairment in patients with the fibromyalgia syndrome and systemic sclerosis.

Authors:  Howard Amital; Nancy Agmon-Levin; Netta Shoenfeld; Yoav Arnson; Daniela Amital; Pnina Langevitz; Alexandra Balbir Gurman; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2.  Coping profiles and health outcomes among individuals with systemic sclerosis: A latent profile analysis approach.

Authors:  Shelley E Condon; Scott C Roesch; Philip J Clements; Daniel E Furst; Michael H Weisman; Vanessa L Malcarne
Journal:  J Scleroderma Relat Disord       Date:  2020-06-22

3.  Longitudinal patterns of pain in patients with diffuse and limited systemic sclerosis: integrating medical, psychological, and social characteristics.

Authors:  Erin L Merz; Vanessa L Malcarne; Scott C Roesch; Deepthi K Nair; Gloria Salazar; Shervin Assassi; Maureen D Mayes
Journal:  Qual Life Res       Date:  2016-07-28       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.